Herui Yao

机构：Sun Yat-sen University, Sun Yat-sen Memorial Hospital · ORCID：0000-0001-5520-6469

发表论文 376 篇 · 总被引 14605 次 · h-index 53

代表论文

• Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (2025 · New England Journal of Medicine · 被引 46)
• First-in-human study of JSKN016, a bispecific anti-TROP2/HER3 antibody drug conjugate (ADC): Antitumor activity in patients (pts) with metastatic triple-negative breast cancer (mTNBC) and safety results. (2025 · Journal of Clinical Oncology · 被引 9)
• EGFR TKIs suppress MUC1 glycosylation through the PI3K/AKT/SP1/C1GALT1 pathway to enhance TnMUC1 CAR-T efficacy in EGFR-mutant NSCLC (2025 · Cell Reports Medicine · 被引 8)
• LBA19 SHR-A1811 versus pyrotinib plus capecitabine in human epidermal growth factor receptor 2-positive (HER2+) advanced/metastatic breast cancer (BC): A multicenter, open-label, randomized, phase III study (HORIZON-Breast01) (2025 · Annals of Oncology · 被引 5)
• A foundation model for predicting outcomes of neoadjuvant chemotherapy in breast cancer (2025 · International Journal of Surgery · 被引 2)
• Single-cell RNA sequencing identifies CD8Teff cell activation as a predictive biomarker in triple-negative breast cancer immunotherapy (2025 · Molecular Biomedicine · 被引 2)